Patent US4268516A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4268516A Expired / Lapsed US ⏱️ 0.0 years remaining

[1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents

Assignee: Pfizer Inc
•
Filing: 1980-03-24
•
Granted: 1981-05-19
•
Expires: 2000-03-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1,2,3,4-Tetrahydrobenzothiopyrano[4,3-c]pyrazol-3-ones and 2,3-dihydro[1]benzothiopyrano[4,3-c]pyrazol-3-ones, of respective structure I and II, <IMAGE> I +TR <IMAGE> II wherein n is an integer of value from 0 to 2; R is phenyl; phenyl monosubstituted with chloro, bromo, fluoro, methyl, methoxy, nitro or trifluoromethyl; or phenyl disubstituted with chloro; and X is hydrogen or chloro; are described. These novel compounds are immunoregulators which, through suppression of the immune response in mammals, are useful in inhibiting rejection of organ transplants, as well as in the therapy of auto-immune diseases.

Inventors

  • 👤 Joseph G. Lombardino
  • 👤 Ivan G. Otterness
  • 👤 James F. Muren

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 20:52
CPC Classifications
C; C07; C07D; C07D495/00; C07D495/02; C07D495/04

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 45 words
A compound of structure: ##STR8## wherein n is an integer of value from 0 to 2; R is phenyl; phenyl monosubstituted with chloro, bromo, fluoro, methyl, methoxy, nitro or trifluoromethyl; or phenyl disubstituted with chloro in other than 2,6-position; and X is hydrogen or chloro.
Claim 2
Dependent Claim 45 words
A compound of structure: ##STR8## wherein n is an integer of value from 0 to 2; R is phenyl; phenyl monosubstituted with chloro, bromo, fluoro, methyl, methoxy, nitro or trifluoromethyl; or phenyl disubstituted with chloro in other than 2,6-position; and X is hydrogen or chloro.
Claim 3
Dependent Claim 22 words
A compound of claim 1 wherein X is hydrogen and R is phenyl mono-substituted in the 4-position with chloro, bromo or fluoro.
Claim 4
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 5
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 6
Dependent Claim 1 words
2-(4-Bromophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 7
Dependent Claim 1 words
2-(4-Bromophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 8
Dependent Claim 1 words
2-(4-Fluorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 9
Dependent Claim 1 words
2-(4-Fluorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 10
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one-5-oxide.
Claim 11
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one-5-oxide.
Claim 12
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one-5,5-dioxide.
Claim 13
Dependent Claim 1 words
2-(4-Chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one-5,5-dioxide.
Claim 14
Dependent Claim 1 words
2-(4-Chlorophenyl)-2,3-dihydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 15
Dependent Claim 1 words
2-(4-Chlorophenyl)-2,3-dihydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 16
Dependent Claim 21 words
A compound of claim 1 wherein X is hydrogen and R is phenyl disubstituted in the 3,4- or 3,5-position with chloro.
Claim 17
Dependent Claim 1 words
2-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 18
Dependent Claim 1 words
2-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 19
Dependent Claim 29 words
A pharmaceutical composition suitable for oral or parenteral administration in suppressing body immune responses comprising a pharmaceutically-acceptable carrier and an immune suppressing amount of a compound of claim 1.
Claim 20
Dependent Claim 11 words
A pharmaceutical composition of claim 11 wherein the compound is 2-(4-chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 21
Dependent Claim 11 words
A pharmaceutical composition of claim 11 wherein the compound is 2-(4-bromophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one
Claim 22
Dependent Claim 11 words
A pharmaceutical composition of claim 11 wherein the compound is 2-(4-fluorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 23
Dependent Claim 11 words
A pharmaceutical composition of claim 11 wherein the compound is 2-(4-chlorophenyl)-2,3-dihydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 24
Dependent Claim 11 words
A pharmaceutical composition of claim 11 wherein the compound is 2-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 25
Dependent Claim 38 words
A method of suppressing body immune responses in a mammal, other than a rabbit, in need of such treatment comprising orally or parenterally administering a body immune suppressing amount of a compound of claim 1 to said mammal.
Claim 26
Dependent Claim 10 words
A method of claim 17 wherein the compound is 2-(4-chlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 27
Dependent Claim 10 words
A method of claim 17 wherein the compound is 2-(4-bromophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 28
Dependent Claim 10 words
A method of claim 17 wherein the compound is 2-(4-fluorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 29
Dependent Claim 10 words
A method of claim 17 wherein the compound is 2-(4-chlorophenyl)-2,3-dihydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.
Claim 30
Dependent Claim 10 words
A method of claim 17 wherein the compound is 2-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazol-3-one.

References Cited (Backward Citations)

US3235564A Cited
US3816438A Cited
US3932434A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-18 1984-11-17 1985-05-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-18 1988-11-17 1989-05-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-18 1992-11-17 1993-05-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag